(Q33649871)

28 July 2017

1 reference

title

Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome (English)

1 reference

28 July 2017

0 references

B Stegmayr

1

1 reference

28 July 2017

publication date

1 March 1999

1 reference

Clinical Chemistry and Laboratory Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

37

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

327-332

1 reference

Organ-specific therapy in critical illness: interfacing molecular mechanisms with physiological interventions

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Prognosis in acute organ-system failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Reversal of late septic shock with supraphysiologic doses of hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Polymyxin-dextran antiendotoxin pretreatment in an ovine model of normotensive sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Multiple organ failure--a role for plasma exchange?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Plasma exchange and haemodiafiltration in fulminant meningococcal sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.055

21 January 2018

Identifiers

DOI

10.1515/CCLM.1999.055

1 reference

28 July 2017

1 reference